PATENT CLAIM ANALYSIS

Application Number: 15999239
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-04
Patent Classification: ["424", "085400"]

Abstract:
Methods of treating a hepatitis delta virus (HDV) infection in a human patient are provided. In some embodiments, the method comprising administering to the patient a therapeutically effective amount of interferon lambda for at least four weeks.

Claim (Index 17):
The method of any of  claims 1  to  16 , wherein prior to the onset of treatment, the patient has a serum alanine aminotransferase (ALT) level that is above the upper limit of normal (ULN), and the course of treatment results in an improvement in serum ALT level in the patient to a level that is within the ULN.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 96.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15335327', '13875253', '13119760', '15408087', '14449174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.742602368873591
- 35 USC 102 Novelty (BERT): 0.5373182374081289
- Combined Prediction Score: 0.7220739557270448
- Mean Citation Score: 274.69786200000004
- Max Citation Score: 376.35223
- Similarity Product: 238.5052030600721

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test